|
|
|
Register by March 9 to SAVE up to $200
|
A number of breakthrough technologies are being incorporated into novel diagnostics to detect a range of molecular and protein biomarkers. The diagnostic methods applied will include PCR, microarrays, sequencing, proteomics, methylation, and mutation detection. This meeting will highlight the next generation of diagnostic platforms that encompass the latest trends in microfluidics, point-of-care technologies, in vivo sensing, and consumer-driven products. A panel of experts will focus on translation to the medical community and the key to success in implementation.
Topics include:
- Microfluidic Technology and Business Trends
- Point-of-Care Diagnostics
- Nanotechnology Advances
- Innovation in Microfluidics
- In vivo Diagnostic Imaging
- Recent Approvals of Companion Diagnostics
Scientific Advisory Board:
John C. Carrano, Ph.D., President, Carrano Consulting, LLC John J. Krolewski, M.D., Ph.D., Professor, Pathology & Laboratory Medicine, University of California, Irvine Young Jik Kwon, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, Department of Chemical Engineering and Materials Science, University of California, Irvine Frank L. Meyskens, Jr., M.D., Director, Chao Family Cancer Center, University of California, Irvine Edward L. Nelson, M.D., FACP, Chief, Heme/Onc Division, Associate Professor, Medicine and of Molecular Biology & Biochemistry, University of California, Irvine Jennifer Prescher, Ph.D., University of California, Irvine Gregory A. Weiss, Ph.D., Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine | Conference Chairman
Pre-Conference Short Courses
Sunday, April 15: 1-4pm
12:00-1:00pm Short Course Registration
Microfluidics Technology and Market Trends*
In recent years, microfluidic and micro/nano technologies have transformed research and experienced impressive market growth allowing novel applications and market avenues. The impact of these enabling technologies will make it essential to adapt current strategies to meet future demands. This course will bring attendees up to date on technological advances, commercial applications of microfluidic technology, and market trends. Macroeconomic and regulatory aspects in the commercialization of new diagnostics products based on those micro technologies are becoming more and more urgent topics in the invention and development of new products. An overview of the microfluidic market for in vitro diagnostics will be presented as well as keys to market entry and future perspectives.
Speakers:
Richard Selden, M.D., Ph.D., CEO, NetBio
Ali Tinazli, Director, Business Development & Sales, BioSciences - North America, Sony DADC Austria AG
Leanna Levine, Ph.D., President and CEO, ALine, Inc.
Click here for a detailed agenda
*Separate Registration Required
*This course is not CME accredited
Tuesday, April 17 | 6:30-8:30 pm
Guidelines for Commercial Launch of Novel Diagnostics
- Medical Necessity
- Assay Validation
- Regulatory Pathway and Considerations
- Reimbursement
- Acceptance and Adoption
- Economic Impact of Pre-analytical Errors
- Cost Effectiveness of Investment in the Pre-analytical Process
Instructors:
Bill Cook, Principal, WECA
Dwight Denham, MBA, Director, Clinical Research, Health Economics &. Reimbursement Affairs (CHRA), Beckman Coulter, Inc.
*Separate Registration Required
*This course is not CME accredited
|
|
|
Conference
& Course Catalog
|